Deal snapshot: CSL Eyes Close of Vifor Pharma Acquisition.

MANews-(C)2009-2022

Australian biotechnology company CSL Ltd. (ASX: CSL) (OTC: CSLLY) has now received all necessary regulatory clearances for the acquisition of Swiss specialty pharmaceutical company Vifor Pharma Ltd (SIX: VIFN; ISIN: CH0364749348) announced on 14 December 2021, the company said.

...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT